OSM Industry Intel • Summer 2026 The Brain’s Immune Cells Get Stuck in Attack Mode. The Fix Is Not More Antioxidant. It Is the Right Amount. A new Frontiers in Nutrition review reframes neuroprotection around microglial immune state and a dose-response curve that is shaped like an upside-down U. The implication for formulators is uncomfortable […]
Learn More
OSM Industry Intel • Spring 2026 The NIH Just Tested 8 Longevity Compounds. All 8 Failed. The Reason Should Change How You Formulate. The gold-standard longevity screen posted a clean sweep of nulls in 2026, including a compound that passed the same test three years ago. The dose gap between those two results is the […]
Learn More
OSM Industry Intel • Spring 2026 Science Just Found the Cellular “Toxic Waste Leak” Behind Inflammaging. Here Is the Supplement Angle. A 2025 review pulls together a striking discovery: aging immune cells lose the ability to take out their own cellular trash, then leak mitochondrial DNA that the body mistakes for a viral invasion. The […]
Learn More
OSM Industry Intel • Spring 2026 American Elderberry Juice Just Posted a Signal for Cognitive Flexibility in Mild Cognitive Impairment A new randomized clinical trial in Antioxidants shows daily elderberry juice consumption improved cognitive flexibility speed in older adults with mild cognitive impairment after six months. Here is what supplement brands should be paying attention […]
Learn More
The NAD+ Supplement Hype—Is It Backed by Science? In the world of anti-aging supplements, NAD+ precursors have become one of the most heavily marketed solutions. These compounds are designed to boost levels of nicotinamide adenine dinucleotide (NAD+), a molecule involved in cellular energy and mitochondrial function. As we age, NAD+ levels naturally decline, and many […]
Learn More